Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of Moderna’s COVID-19 Vaccine or Updated Booster Candidate in 2022:Agreement includes 15 million doses for delivery in the third quarter of 2022 and 5 million doses for delivery in the fourth quarter of 2022
Moderna is oversold. After trading for more than 20 years I have found that it is not a good idea to sell or short a stock after a significant decline, especially near a support level. It has bounced from this support at 225 in November and I believe that it will bounce again this time given that COVID cases are rising exponentially surpassed 1 million.$Moderna, Inc.(MRNA)$
精彩评论